Discoveries from the study of longstanding type 1 diabetes
Controlling Type 1 Diabetes | UHN Research
Kidney Foundation - The Kidney Foundation of Canada
Canadian Diabetes Association Clinical Practice Guidelines Neuropathy Chapter 31 Vera Bril, Bruce Perkins, Cory Toth. - ppt download
News - Sinai Health Foundation
A Diabetes-Researcher Approved Reading List | by Krista Lamb | Medium
Perkins, Bruce - Banting & Best Diabetes Centre
New podcast episode! 🎙️ Dr. Bruce Perkins from the @uoft and Mount Sinai Hospital studies the complications of diabetes and ways to improve... | By Diabetes Canada | Facebook
CWMGR: The Expanding Multiverse of SGLTi In & Beyond Diabetes - YouTube
Stream Diabetes Canada | Listen to podcast episodes online for free on SoundCloud
The Authors Reply:
Dr. Bruce Perkins takes on Directorship of Leadership Sinai Centre for Diabetes - Sinai Health
DU 20 Invite Two Pager_Virtual v6
Canadian Diabetes Association Clinical Practice Guidelines Neuropathy Chapter 31 Vera Bril, Bruce Perkins, Cory Toth. - ppt download
Bruce A Perkins | UHN Research
DU 20 Invite Two Pager PDF_v24
/cloudfront-eu-central-1.images.arcpublishing.com/madsack/D4FRFXWSZVBBPM2HMJAYLYX6JQ.jpg "Diabetes Typ 1: 100 Jahre Insulin – und wie sich die Therapie entwickelt")
Diabetes Typ 1: 100 Jahre Insulin – und wie sich die Therapie entwickelt
Diabetes Canada on Twitter: "Congratulations as well to Dr. Bruce Perkins, winner of the CDA 2015 Young Scientist Award! (photo by @JulianFok) https://t.co/cyEbAS5Gzm"
:format(webp)/https://www.thestar.com/content/dam/thestar/life/health_wellness/nutrition/2014/05/22/many_type_1_diabetics_living_with_disease_50plus_years_study_seeks_to_know_why/diabetes_type_1.jpg "Many Type 1 diabetics living with disease 50-plus years, study seeks to know why | The Star")
Many Type 1 diabetics living with disease 50-plus years, study seeks to know why | The Star
Bruce Perkins - The Sam and Judy Pencer Family Chair in Diabetes and Director of the Diabetes Clinical Research Unit - Leadership Sinai Centre for Diabetes | LinkedIn
What We Say and What We Don't Say : Type 1 Diabetes | Health Choices First
Diabetes Action Canada Research Published in Nature Medicine – Diabetes Action Canada
Diabetes + Endless Possibility - Sinai Health Foundation
The sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin improves glycaemic control in patients with type 1 diabetes: a single-arm clinical trial - Media Centre | EASD
:format(webp)/https://www.thespec.com/content/dam/thespec/life/health-wellness/2014/05/16/study-probes-longevity-of-diabetics/B821611120Z.1_20140515133750_000_G5C189639.2_Gallery.jpg "Study probes longevity of diabetics | TheSpec.com")
Study probes longevity of diabetics | TheSpec.com
